Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia: a retrospective study
- PMID: 36409364
- PMCID: PMC10154271
- DOI: 10.1007/s00467-022-05784-y
Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia: a retrospective study
Abstract
Background: Primary hyperoxalurias (PHs) constitute rare disorders resulting in abnormal glyoxalate metabolism. PH-associated phenotypes range from progressive nephrocalcinosis and/or recurrent urolithiasis to early kidney failure.
Methods: A retrospective study was conducted for patients with confirmed PH diagnoses from three tertiary centers in Saudi Arabia. Detailed clinical molecular diagnosis was performed for 25 affected individuals. Whole exome sequencing (WES)-based molecular diagnosis was performed for all affected individuals.
Results: The male:female ratio was 52% male (n = 13) and 48% female (n = 12), and consanguinity was present in 88%. Nephrolithiasis and/or nephrocalcinosis were present in all patients. Kidney stones were present in 72%, nephrocalcinosis in 60%, hematuria in 32%, proteinuria in 16%, abdominal pain in 36%, developmental delay in 8%, and chronic kidney disease stage 5 (CKD stage 5) was observed in 28% of the patients. The most common PH disorder was type I caused by variants in the AGXT gene, accounting for 56%. The GRHPR gene variants were identified in 4 patients, 16% of the total cases. Seven patients did not reveal any associated variants. Missense variants were the most commonly observed variants (48%), followed by frame-shift duplication variants (28%).
Conclusions: Characterization of the genetic and clinical aspects of PH in this unique population provides direction for improved patient management and further research. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keywords: AGXT; GRHPR; Nephrocalcinosis; Primary hyperoxaluria; Saudi Arabia.
© 2022. The Author(s).
Conflict of interest statement
None.
Figures
Similar articles
-
[Clinical analysis of seven cases with primary hyperoxaluria type 1 in children].Zhonghua Er Ke Za Zhi. 2020 Feb 2;58(2):129-134. doi: 10.3760/cma.j.issn.0578-1310.2020.02.012. Zhonghua Er Ke Za Zhi. 2020. PMID: 32102150 Review. Chinese.
-
Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.Nephrol Ther. 2017 May;13(3):176-182. doi: 10.1016/j.nephro.2016.08.002. Epub 2017 Feb 1. Nephrol Ther. 2017. PMID: 28161266 Free PMC article.
-
Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome.Pediatr Nephrol. 2023 Aug;38(8):2643-2648. doi: 10.1007/s00467-023-05917-x. Epub 2023 Mar 14. Pediatr Nephrol. 2023. PMID: 36917293
-
Diagnostic policies on nephrolithiasis/nephrocalcinosis of possible genetic origin by Italian nephrologists: a survey by the Italian Society of Nephrology with an emphasis on primary hyperoxaluria.J Nephrol. 2023 Jul;36(6):1605-1614. doi: 10.1007/s40620-023-01693-x. Epub 2023 Jun 26. J Nephrol. 2023. PMID: 37358729 Free PMC article.
-
The primary hyperoxalurias: an algorithm for diagnosis.Am J Nephrol. 2005 Mar-Apr;25(2):154-60. doi: 10.1159/000085407. Epub 2005 Apr 22. Am J Nephrol. 2005. PMID: 15855742 Review.
Cited by
-
Primary hyperoxaluria type 1: Clinical, genetic, and evolutionary characteristics in Tunisian children.Tunis Med. 2023 Jul 5;101(7):626-630. Tunis Med. 2023. PMID: 38445424 Free PMC article. French.
-
Clinical characteristics, genetic profile and short-term outcomes of children with primary hyperoxaluria type 2: a nationwide experience.Pediatr Nephrol. 2024 Apr;39(4):1093-1104. doi: 10.1007/s00467-023-06200-9. Epub 2023 Nov 2. Pediatr Nephrol. 2024. PMID: 37914965 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical